SCHEMBL6961069

SCHEMBL6961069

COC(=O)c1cccc(COc2ccc(-c3cc(O)c(SCCc4ccccc4)c(=O)o3)cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 4/20 0.48
ADAMTS4 O75173 1/20 0.45
MMP13 P45452 1/20 0.45
PRKDC P78527 1/20 0.45
ABCG2 Q9UNQ0 6/20 0.43
ABCB1 P08183 5/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TP53 P04637 1/20 0.43
PKM P14618 1/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
ABCC1 P33527 3/20 0.41
LMNA P02545 2/20 0.41
HPGD P15428 1/20 0.41
GCGR P47871 1/20 0.41
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6952662 0.92 PTPN7 (0.47) PRKDCABCB1RAB9ASMN1; SMN2LMNA
SCHEMBL6953671 0.91 MRGPRX4 (0.48) MRGPRX4RAB9ASMN1; SMN2TP53PKM
SCHEMBL6952547 0.87 ABCB1 (0.50) PRKDCABCB1LMNA
SCHEMBL6965449 0.86 PTGER4 (0.39) ABCB1SMN1; SMN2LMNAHPGDKDM4E
SCHEMBL6954678 0.83 ABCB1 (0.43) MRGPRX4ADAMTS4MMP13PRKDCABCB1
SCHEMBL8586973 0.82 POLB (0.44) PRKDCABCB1SMN1; SMN2PKMHPGD
SCHEMBL6963884 0.82 GSK3B (0.48) RAB9ASMN1; SMN2LMNAHPGDNPC1
SCHEMBL6952541 0.82 MAOB (0.45) MRGPRX4PRKDCABCB1
SCHEMBL6963360 0.82 CYP19A1 (0.46) PRKDCABCB1SMN1; SMN2NPC1
SCHEMBL6956259 0.81 XDH (0.48) ABCG2ABCB1SMN1; SMN2HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP claimed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO claimed
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed